thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35848351-369D4475-DCF4-4F09-BC90-4831BAA457B6
Q35848351-369D4475-DCF4-4F09-BC90-4831BAA457B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35848351-369D4475-DCF4-4F09-BC90-4831BAA457B6
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma
P2860
Q35848351-369D4475-DCF4-4F09-BC90-4831BAA457B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35848351-369D4475-DCF4-4F09-BC90-4831BAA457B6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6e0321d62a97834eaeb0e62e8ffe048ef9dfba4c
P2860
Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.